Exclusive: Pfizer to cut U.S. sales staff
Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects
The S&P 500 (.SPX) and Dow Jones Industrial Average (.DJI) posted closing record highs on the first trading
Shares of Pfizer Inc (PFE.N) hit a record high on Tuesday for the first time in
BioNTech and partner Pfizer (PFE.N) have supplied more than one billion doses of their COVID-19 vaccine
Second-quarter sales of AstraZeneca's (AZN.L) COVID-19 vaccine more than tripled to $894 million from
The United States will spend $3.5 billion to buy and donate 500 million doses
Wall Street ended a see-saw session lower on Wednesday as market participants awaited inflation
United Parcel Service Inc (UPS.N) shares fell as much as 6% on Wednesday as